Pulmonary Fibrosis: Clinical Trials

1 trial for Pulmonary Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Pulmonary Fibrosis: new trials by email Literature Review of Pulmonary Fibrosis trials Research Report on Pulmonary Fibrosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhaled NAC in Treatment of IPF
N-acetyl cysteine then Placebo, Placebo then N-acetyl cysteine - Idiopathic Pulmonary Fibrosis (IPF)
Phase 1 / Phase 2WithdrawnUniversity of Colorado, Denver2022-01-012021-06-08

Narrower conditions

Idiopathic Pulmonary Fibrosis (1)

Broader conditions

Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Respiratory Tract Diseases (1)

Sponsors

University of Colorado, Denver (1)

Countries

United States (1)

Top investigators

Mark Steele, MD (1)